Browse studies

Find your next paid study

70 recruiting studies matching your filters

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for pat…

Atopic Dermatitis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

CorEvitasNCT04504955

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

The goal of this observational study is to learn about exposure to tralokinumab during pregnancy, as well as atopic dermatitis (AD) during pregnancy. The main…

Atopic DermatitisEczema

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, San DiegoNCT05938478

Pregnancy Outcomes Study of Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

This study is to assess infant outcomes of women with AD who were exposed to ruxolitinib cream during pregnancy compared with a control cohort of women with AD…

Pregnancy RelatedAtopic Dermatitis

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Incyte CorporationNCT06627335

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ENV-294 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

The goal of this clinical trial is to learn about the safety and effectiveness of ENV-294 in adults with moderate to severe atopic dermatitis. The main questi…

Atopic Dermatitis (AD)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Enveda TherapeuticsNCT07298395

Phase 2

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Platform Study to Assess the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

Atopic Dermatitis

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT06947993

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient report…

Atopic Dermatitis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Galderma R&DNCT06988605

Phase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy, pharmacokinetics, and Safety of repeat subcutaneous doses of FB825 in…

Atopic Dermatitis

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Oneness Biotech Co., Ltd.NCT06397911

Phase 2

A Phase 2b, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Atopic DermatitisAtopic Dermatitis EczemaEczema

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Inmagene LLCNCT07037901

Observational

Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project

This study will explore potential links between atopic dermatitis and food allergy. This information will be useful to determine atopic dermatitis and food all…

Atopic DermatitisFood AllergyHealthy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT06300697

Phase 4

A Phase 4, Open Label Study to Assess Descriptive Classification of Pruritus Over Time With Roflumilast 0.15% Cream in Patients With Atopic Dermatitis

This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in pa…

ITCHAtopic Dermatitis

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Integrative Skin Science and ResearchNCT07560618

Phase 4

Opzelura Experience Study

Atopic dermatitis is a common multifactorial skin disease. Topicals are the mainstay of treatment, but adherence to topicals is often abysmal, possibly worsene…

Atopic Dermatitis

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT07661979

Phase 1

A Multi-part, FiH Study in Healthy Participants and Participants With Atopic Dermatitis (AD) to Assess the Safety, Tolerability, Pharmacokinetics (PK) of Single & Multiple Ascending Doses and Selected Dose of SYX-5219 (AD Participants).

The purpose of this study is to evaluate the study drug, SYX-5219, in a multi-part First-in-Human (FiH) study to be conducted in healthy volunteers and partici…

Moderate to Severe Atopic Dermatitis

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Sitryx Therapeutics LtdNCT07558668